Ishaque Muhammed, Rashid Rahma, Mubarak Muhammed
Javed I. Kazi Department of Histopathology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan.
Indian J Gastroenterol. 2015 Jan;34(1):51-7. doi: 10.1007/s12664-015-0537-8. Epub 2015 Mar 12.
Renal transplantation is the treatment of choice for patients with end-stage renal disease. The renal transplant recipients are susceptible to a variety of gastrointestinal (GI) complications such as infections, ulcer disease, and malignancies.
We aimed to determine the frequency of pathological lesions in GI endoscopic biopsies in recipients of live related renal transplantation in our setting.
This retrospective survey was carried out at Histopathology Department of Sindh Institute of Urology and Transplantation, Karachi, from December 2010 to January 2011. All consecutive renal transplant patients of all ages and both genders on regular follow up, presenting with GI complaints and in whom GI endoscopic biopsies were performed, were included. The demographic, clinical, and laboratory data were retrieved from case files and the pathological diagnoses from the original biopsy reports.
A total of 200 consecutive renal transplant patients were enrolled. The biopsies comprised of 19 (9.5 %) esophageal biopsies, 119 (59.5 %) gastric biopsies, 148 (74 %) duodenal biopsies, and 66 (33 %) colorectal biopsies. The main pathological lesions included cytomegalovirus infection in 22 (11 %) of all patients, Helicobacter pylori in 11 (9.2 %) of gastric biopsies, cryptosporidium in 4 (1.6 %), giardiasis in 30 (15 %), immunoproliferative small intestinal disease in 5 (3.4 %), tropical sprue in 33 (15 %), tuberculosis in 3 (2 %) of the small intestinal biopsies, and gastric adenocarcinoma in 1 (1.7 %) gastric biopsy.
A wide spectrum of pathological lesions including opportunistic infections was seen in GI endoscopic biopsies in renal transplant patients. Endoscopic biopsies play an important role in the diagnosis and management of GI disease in renal transplant patients.
肾移植是终末期肾病患者的首选治疗方法。肾移植受者易发生各种胃肠道并发症,如感染、溃疡病和恶性肿瘤。
我们旨在确定在我们的研究环境中,活体亲属肾移植受者胃肠道内镜活检中病理病变的发生率。
这项回顾性调查于2010年12月至2011年1月在卡拉奇信德泌尿学与移植研究所组织病理学部门进行。纳入所有年龄和性别的连续肾移植患者,这些患者定期随访,出现胃肠道症状并接受了胃肠道内镜活检。从病例档案中检索人口统计学、临床和实验室数据,并从原始活检报告中获取病理诊断结果。
共纳入200例连续肾移植患者。活检包括19例(9.5%)食管活检、119例(59.5%)胃活检、148例(74%)十二指肠活检和66例(33%)结肠直肠活检。主要病理病变包括:所有患者中有22例(11%)发生巨细胞病毒感染,胃活检中有11例(9.2%)感染幽门螺杆菌,4例(1.6%)感染隐孢子虫,30例(15%)感染贾第虫,5例(3.4%)发生免疫增殖性小肠疾病,33例(15%)发生热带口炎性腹泻,小肠活检中有3例(2%)发生结核病,胃活检中有1例(1.7%)发生胃腺癌。
肾移植患者胃肠道内镜活检中可见包括机会性感染在内的多种病理病变。内镜活检在肾移植患者胃肠道疾病的诊断和管理中发挥着重要作用。